Genetic Predisposition to Gynecological Cancers: Understanding the Role of Genetic Variants and Familial Risk

Abstract

The abstract will provide an extensive summary of the study, introducing the relevance of genetic predisposition in the development of gynecological cancers (e.g., ovarian, endometrial, cervical). It will highlight the identification of high-risk genes such as BRCA1, BRCA2, and Lynch syndrome genes, alongside the importance of genomic screening tools. The methodology will emphasize comprehensive genetic testing and statistical analyses used to examine familial patterns. Results will summarize key genetic markers identified and their implications for screening and early detection. The conclusion will underscore the clinical implications and future research directions necessary for improving patient outcomes.